{"title":"采访外科肿瘤学家罗伯特·n·格里夫医生","authors":"C. Woodford","doi":"10.5015/UTMJ.V87I3.1264","DOIUrl":null,"url":null,"abstract":"Dr. Robert N. Gryfe is a colorectal surgical oncologist at Mount Sinai and Princess Margaret Hospitals and researcher at Mount Sinai’s Samuel Lunenfeld Research Institute. Dr. Gryfe's clinical practice specializes in the management of patients with colon and rectal cancer and hereditary cancer syndromes. His research laboratory investigates the genetic determinants of colorectal cancer risk, prognosis and response to chemotherapy.","PeriodicalId":41298,"journal":{"name":"University of Toronto Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2010-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An Interview with Dr. Robert N. Gryfe, Surgical Oncologist\",\"authors\":\"C. Woodford\",\"doi\":\"10.5015/UTMJ.V87I3.1264\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dr. Robert N. Gryfe is a colorectal surgical oncologist at Mount Sinai and Princess Margaret Hospitals and researcher at Mount Sinai’s Samuel Lunenfeld Research Institute. Dr. Gryfe's clinical practice specializes in the management of patients with colon and rectal cancer and hereditary cancer syndromes. His research laboratory investigates the genetic determinants of colorectal cancer risk, prognosis and response to chemotherapy.\",\"PeriodicalId\":41298,\"journal\":{\"name\":\"University of Toronto Medical Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2010-06-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"University of Toronto Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5015/UTMJ.V87I3.1264\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"University of Toronto Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5015/UTMJ.V87I3.1264","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
Robert N. Gryfe博士是Mount Sinai和Princess Margaret Hospitals的结直肠外科肿瘤学家，Mount Sinai ' s Samuel Lunenfeld Research Institute的研究员。Gryfe博士的临床实践专长于结肠癌、直肠癌和遗传性癌症综合征患者的管理。他的研究实验室研究结直肠癌风险、预后和化疗反应的遗传决定因素。
An Interview with Dr. Robert N. Gryfe, Surgical Oncologist
Dr. Robert N. Gryfe is a colorectal surgical oncologist at Mount Sinai and Princess Margaret Hospitals and researcher at Mount Sinai’s Samuel Lunenfeld Research Institute. Dr. Gryfe's clinical practice specializes in the management of patients with colon and rectal cancer and hereditary cancer syndromes. His research laboratory investigates the genetic determinants of colorectal cancer risk, prognosis and response to chemotherapy.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
